0.027123
0.000000
0.000000
0.000000
0.016315
0.000000
0.000000
0.000000
0.013890
0.00000
0.00000
0.00000
VAL C 5 - LEU C 6 OMEGA = 359.98 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
Mikol, V.
Kallen, J.
Walkinshaw, M.D.
http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic
4
90.00
90.00
90.00
36.869
61.292
71.993
C4 H9 N O2
103.120
n
ALPHA-AMINOBUTYRIC ACID
L-peptide linking
C3 H7 N O2
89.093
y
ALANINE
L-peptide linking
C6 H15 N4 O2 1
175.209
y
ARGININE
L-peptide linking
C4 H8 N2 O3
132.118
y
ASPARAGINE
L-peptide linking
C4 H7 N O4
133.103
y
ASPARTIC ACID
L-peptide linking
C10 H19 N O3
201.263
n
4-METHYL-4-[(E)-2-BUTENYL]-4,N-METHYL-THREONINE
L-peptide linking
C3 H7 N O2 S
121.158
y
CYSTEINE
L-peptide linking
C3 H7 N O2
89.093
D-ALANINE
D-peptide linking
C11 H21 N O3
215.289
3-HYDROXY-4,4-DIMETHYL-2-(METHYLAMINO)-6-OCTENOIC ACID
L-peptide linking
C5 H10 N2 O3
146.144
y
GLUTAMINE
L-peptide linking
C5 H9 N O4
147.129
y
GLUTAMIC ACID
L-peptide linking
C2 H5 N O2
75.067
y
GLYCINE
peptide linking
C6 H10 N3 O2 1
156.162
y
HISTIDINE
L-peptide linking
H2 O
18.015
WATER
non-polymer
C6 H13 N O2
131.173
y
ISOLEUCINE
L-peptide linking
C6 H13 N O2
131.173
y
LEUCINE
L-peptide linking
C6 H15 N2 O2 1
147.195
y
LYSINE
L-peptide linking
C5 H11 N O2 S
149.211
y
METHIONINE
L-peptide linking
C7 H15 N O2
145.199
n
N-METHYLLEUCINE
L-peptide linking
C6 H13 N O2
131.173
n
N-METHYLVALINE
L-peptide linking
C9 H11 N O2
165.189
y
PHENYLALANINE
L-peptide linking
C5 H9 N O2
115.130
y
PROLINE
L-peptide linking
C3 H7 N O2
89.093
n
SARCOSINE
peptide linking
C3 H7 N O3
105.093
y
SERINE
L-peptide linking
C4 H9 N O3
119.119
y
THREONINE
L-peptide linking
C11 H12 N2 O2
204.225
y
TRYPTOPHAN
L-peptide linking
C9 H11 N O3
181.189
y
TYROSINE
L-peptide linking
C5 H11 N O2
117.146
y
VALINE
L-peptide linking
UK
Protein Eng.
PRENE9
0859
0269-2139
7
597
10.1093/PROTEIN/7.5.597
8073029
The X-Ray Structure of (Mebm2T)1-Cyclosporin Complexed with Cyclophilin a Provides an Explanation for its Anomalously High Immunosuppressive Activity.
1994
DK
Acta Crystallogr.,Sect.D
ABCRE6
0766
0907-4449
50
543
10.1107/S0907444994001800
15299416
Crystallization of the Complex between Cyclophilin a and Cyclosporin Derivatives: The Use of Cross- Seeding.
1994
US
J.Med.Chem.
JMCMAR
0151
0022-2623
37
3674
7966126
Improved Binding Affinity for Cyclophilin a by a Cyclosporin Derivative Singly Modified at its Effector Domain.
1994
UK
J.Mol.Biol.
JMOBAK
0070
0022-2836
234
1119
10.1006/JMBI.1993.1664
8263916
X-Ray Structure of a Monomeric Cyclophilin A- Cyclosporin a Crystal Complex at 2.1 A Resolution.
1993
UK
Nature
NATUAS
0006
0028-0836
361
91
10.1038/361091A0
8421501
X-Ray Structure of a Decameric Cyclophilin- Cyclosporin Crystal Complex.
1993
1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
1
x-ray
1
1.0
18036.504
PEPTIDYL-PROLYL CIS-TRANS ISOMERASE A
5.2.1.8
1
man
polymer
4-[(E)-2-BUTENYL]-4,4, N-TRIMETHYL- L-THREONINE AT POSITION 5
1234.651
CYCLOSPORIN A
YES
1
syn
polymer
18.015
water
131
nat
water
PPIASE, ROTAMASE, CYCLOPHILIN A
CYCLOSPORINE, CICLOSPORIN, CICLOSPORINE
no
no
MVNPTVFFDIAVDGEPLGRVSFELFADKVPKTAENFRALSTGEKGFGYKGSCFHRIIPGFMCQGGDFTRHNGTGGKSIYG
EKFEDENFILKHTGPGILSMANAGPNTNGSQFFICTAKTEWLDGKHVVFGKVKEGMNIVEAMERFGSRNGKTSKKITIAD
CGQLE
MVNPTVFFDIAVDGEPLGRVSFELFADKVPKTAENFRALSTGEKGFGYKGSCFHRIIPGFMCQGGDFTRHNGTGGKSIYG
EKFEDENFILKHTGPGILSMANAGPNTNGSQFFICTAKTEWLDGKHVVFGKVKEGMNIVEAMERFGSRNGKTSKKITIAD
CGQLE
A
polypeptide(L)
no
yes
(DAL)(MLE)(MLE)(MVA)(DMT)(ABA)(SAR)(MLE)V(MLE)A
ALLVXAGLVLA
C
polypeptide(L)
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
HUMAN
sample
CYCLOPHILIN
9606
HOMO SAPIENS
CYCLOPHILIN
562
ESCHERICHIA COLI
2.11
41.70
repository
Initial release
Version format compliance
Version format compliance
Atomic model
Database references
Derived calculations
Non-polymer description
Structure summary
Other
1
0
1996-01-29
1
1
2011-06-14
1
2
2011-07-13
1
3
2011-07-27
1
4
2012-12-12
CRYSTAL STRUCTURE OF HUMAN CYCLOPHILIN A COMPLEXED WITH CYCLOSPORIN C
CRYSTAL STRUCTURE OF THE CYCLOPHILIN-LIKE DOMAIN FROM BRUGIA MALAYI COMPLEXED WITH CYCLOSPORIN A
SOLUTION STRUCTURE OF E.COLI CYCLOPHILIN (F112W) COMPLEXED WITH CYCLOSPORIN A
CRYSTAL STRUCTURE OF HUMAN CYCLOPHILIN A COMPLEXED WITH CYCLOSPORIN A
CRYSTAL STRUCTURE OF HUMAN CYCLOPHILIN A COMPLEXED WITH MODIFIED CYCLOSPORIN A AT POSITION 8
CRYSTAL STRUCTURE OF HUMAN CYCLOPHILIN A COMPLEXED WITH CYCLOSPORIN D
CRYSTAL STRUCTURE OF HUMAN CYCLOPHILIN A COMPLEXED WITH CYCLOSPORIN A MODIFIED AT POSITION 7
CRYSTAL STRUCTURE OF HUMAN CYCLOPHILIN A COMPLEXED WITH MODIFIED CYCLOSPORIN D AT POSITION 7
CRYSTAL STRUCTURE OF HUMAN CYCLOPHILIN A COMPLEXED WITH MODIFIED CYCLOSPORIN D AT POSITIONS 5 AND 7.
CRYSTAL STRUCTURE OF HUMAN CYCLOPHILIN A COMPLEXED WITH MODIFIED CYCLOSPORIN D AT POSITIONS 5 AND 7.
CRYSTAL STRUCTURE OF HUMAN CYCLOPHILIN A COMPLEXED WITH MODIFIED CYCLOSPORIN A AT POSITION 8
CRYSTAL STRUCTURE OF HUMAN CYCLOPHILIN A COMPLEXED WITH MODIFIED CYCLOSPORIN A AT POSITION 8
CRYSTAL STRUCTURE OF HUMAN CYCLOPHILIN A COMPLEXED WITH NODIFIED CYCLOSPORIN C AT POSITIONS 1, AND 9
SOLUTION STRUCTURE OF HUMAN CYCLOPHILIN COMPLEXED WIYH CYCLOSPORIN A
SOLUTION STRUCTURE OF HUMAN CYCLOPHILIN COMPLEXED WITH CYCLOSPORIN A
CRYSTAL STRUCTURE OF HUMAN CYCLOPHILIN B COMPLEXED WITH MODIFIED CYCLOSPORIN A
CRYSTAL STRUCTURE OF CTCLOSPORIN-FAB COMPLEX
CRYSTAL STRUCTURE OF CALCINEURIN-CYCLOPHILIN-CYCLOSPORIN COMPLEX
CRYSTAL STRUCTURE OF HUMAN CALCINEURIN COMPLEXED WITH HUMAN CYCLOPHILIN AND CYCLOSPORIN A
CRYSTAL STRUCTURE OF HUMAN CYCLOPHILIN A COMPLEXED WITH MODIFIED CYCLOSPORIN A AT POSITION 6
CRYSTAL STRUCTURE OF PLASMODIUM FALCIPARUM CYCLOPHILIN COMPLEXED WITH CYCLOSPORIN A
CRYSTAL STRUCTURE OF PLASMODIUM FALCIPARUM CYCLOPHILIN (DOUBLE MUTANT) COMPLEXED WITH CYCLOSPORIN A
CRYSTAL STRUCTURE OF TRYPANOSOMA CRUZI CYCLOPHILIN COMPLEXED WITH CYCLOSPORIN A
CRYSTAL STRUCTURE OF HUMAN CYCLOPHILIN C COMPLEXED WITH CYCLOSPORIN A
CRYSTAL STRUCTURE OF HUMAN CYCLOPHILIN J COMPLEXED WITH CYCLOSPORIN A
CRYSTAL STRUCTURE OF CRYPTOSPORIDIUM PARVUM IOWA II CYCLOPHILIN A COMPLEXED WITH CYCLOSPORIN A
CRYSTAL STRUCTURE OF HUMAN CYCLOPHILIN A COMPLEXED WITH CYCLOSPORIN A
CRYSTAL STRUCTURE OF HUMAN CYCLOPHILIN A COMPLEXED WITH MODIFIED CYCLOSPORIN A AT POSITION 5
CRYSTAL STRUCTURE OF MURINE CYCLOPHILIN C COMPLEXED WITH CYCLOSPORIN A
CRYSTAL STRUCTURE OF THE PPIASE DOMAIN OF HUMAN CYCLOPHILIN G COMPLEXED WITH CYCLOSPORIN A
CRYSTAL STRUCTURE OF HUMAN ACETYL-CYPA COMPLEXED WITH CYCLOSPORINE A
CRYSTAL STRUCTURE OF PPIL1 COMPLEXED WITH CYCLOSPORINE A
CRYSTAL STRUCTURE OF HUMAN CYCLOPHILIN D IN COMPLEX WITH CYCLOSPORIN A
CRYSTAL STRUCTURE OF CYCLOSPHILIN A FROM TOXOPLASMA GONDII COMPLEXED WIT CYCLOSPORIN A
SOLUTION STRUCTURE OF THE HUMAN CYCLOSPORIN A COMPLEXED WITH CYCLOSPORIN A
CRYSTAL STRUCTURE OF CYCLOPHILIN FROM LEISHMANIA DONOVANI COMPLEXED WITH CYCLOSPORIN A
Y
1995-09-06
REL
HOH
water
29910
TOLYPOCLADIUM INFLATUM
sample
CYCLOSPORIN IS A CYCLIC UNDECAPEPTIDE.
HERE, CYCLOSPORIN A IS REPRESENTED BY THE SEQUENCE (SEQRES)
Immunosuppressant
CYCLOSPORIN IS A CYCLIC UNDECAPEPTIDE.
CYCLIZATION IS ACHIEVED BY LINKING THE N- AND
THE C- TERMINI.
THE CYCLOSPORIN WAS MODIFIED AT POSITION 5 TO BE
4-[(E)-2-BUTENYL]-4,4,N-TRIMETHYL-L-THREONINE
CYCLOSPORIN A, 5 mutation
Cyclic peptide
HOH
2001
3
HOH
HOH
2001
A
HOH
2002
3
HOH
HOH
2002
A
HOH
2003
3
HOH
HOH
2003
A
HOH
2004
3
HOH
HOH
2004
A
HOH
2005
3
HOH
HOH
2005
A
HOH
2006
3
HOH
HOH
2006
A
HOH
2007
3
HOH
HOH
2007
A
HOH
2008
3
HOH
HOH
2008
A
HOH
2009
3
HOH
HOH
2009
A
HOH
2010
3
HOH
HOH
2010
A
HOH
2011
3
HOH
HOH
2011
A
HOH
2012
3
HOH
HOH
2012
A
HOH
2013
3
HOH
HOH
2013
A
HOH
2014
3
HOH
HOH
2014
A
HOH
2015
3
HOH
HOH
2015
A
HOH
2016
3
HOH
HOH
2016
A
HOH
2017
3
HOH
HOH
2017
A
HOH
2018
3
HOH
HOH
2018
A
HOH
2019
3
HOH
HOH
2019
A
HOH
2020
3
HOH
HOH
2020
A
HOH
2021
3
HOH
HOH
2021
A
HOH
2022
3
HOH
HOH
2022
A
HOH
2023
3
HOH
HOH
2023
A
HOH
2024
3
HOH
HOH
2024
A
HOH
2025
3
HOH
HOH
2025
A
HOH
2026
3
HOH
HOH
2026
A
HOH
2027
3
HOH
HOH
2027
A
HOH
2028
3
HOH
HOH
2028
A
HOH
2029
3
HOH
HOH
2029
A
HOH
2030
3
HOH
HOH
2030
A
HOH
2031
3
HOH
HOH
2031
A
HOH
2032
3
HOH
HOH
2032
A
HOH
2033
3
HOH
HOH
2033
A
HOH
2034
3
HOH
HOH
2034
A
HOH
2035
3
HOH
HOH
2035
A
HOH
2036
3
HOH
HOH
2036
A
HOH
2037
3
HOH
HOH
2037
A
HOH
2038
3
HOH
HOH
2038
A
HOH
2039
3
HOH
HOH
2039
A
HOH
2040
3
HOH
HOH
2040
A
HOH
2041
3
HOH
HOH
2041
A
HOH
2042
3
HOH
HOH
2042
A
HOH
2043
3
HOH
HOH
2043
A
HOH
2044
3
HOH
HOH
2044
A
HOH
2045
3
HOH
HOH
2045
A
HOH
2046
3
HOH
HOH
2046
A
HOH
2047
3
HOH
HOH
2047
A
HOH
2048
3
HOH
HOH
2048
A
HOH
2049
3
HOH
HOH
2049
A
HOH
2050
3
HOH
HOH
2050
A
HOH
2051
3
HOH
HOH
2051
A
HOH
2052
3
HOH
HOH
2052
A
HOH
2053
3
HOH
HOH
2053
A
HOH
2054
3
HOH
HOH
2054
A
HOH
2055
3
HOH
HOH
2055
A
HOH
2056
3
HOH
HOH
2056
A
HOH
2057
3
HOH
HOH
2057
A
HOH
2058
3
HOH
HOH
2058
A
HOH
2059
3
HOH
HOH
2059
A
HOH
2060
3
HOH
HOH
2060
A
HOH
2061
3
HOH
HOH
2061
A
HOH
2062
3
HOH
HOH
2062
A
HOH
2063
3
HOH
HOH
2063
A
HOH
2064
3
HOH
HOH
2064
A
HOH
2065
3
HOH
HOH
2065
A
HOH
2066
3
HOH
HOH
2066
A
HOH
2067
3
HOH
HOH
2067
A
HOH
2068
3
HOH
HOH
2068
A
HOH
2069
3
HOH
HOH
2069
A
HOH
2070
3
HOH
HOH
2070
A
HOH
2071
3
HOH
HOH
2071
A
HOH
2072
3
HOH
HOH
2072
A
HOH
2073
3
HOH
HOH
2073
A
HOH
2074
3
HOH
HOH
2074
A
HOH
2075
3
HOH
HOH
2075
A
HOH
2076
3
HOH
HOH
2076
A
HOH
2077
3
HOH
HOH
2077
A
HOH
2078
3
HOH
HOH
2078
A
HOH
2079
3
HOH
HOH
2079
A
HOH
2080
3
HOH
HOH
2080
A
HOH
2081
3
HOH
HOH
2081
A
HOH
2082
3
HOH
HOH
2082
A
HOH
2083
3
HOH
HOH
2083
A
HOH
2084
3
HOH
HOH
2084
A
HOH
2085
3
HOH
HOH
2085
A
HOH
2086
3
HOH
HOH
2086
A
HOH
2087
3
HOH
HOH
2087
A
HOH
2088
3
HOH
HOH
2088
A
HOH
2089
3
HOH
HOH
2089
A
HOH
2090
3
HOH
HOH
2090
A
HOH
2091
3
HOH
HOH
2091
A
HOH
2092
3
HOH
HOH
2092
A
HOH
2093
3
HOH
HOH
2093
A
HOH
2094
3
HOH
HOH
2094
A
HOH
2095
3
HOH
HOH
2095
A
HOH
2096
3
HOH
HOH
2096
A
HOH
2097
3
HOH
HOH
2097
A
HOH
2098
3
HOH
HOH
2098
A
HOH
2099
3
HOH
HOH
2099
A
HOH
2100
3
HOH
HOH
2100
A
HOH
2101
3
HOH
HOH
2101
A
HOH
2102
3
HOH
HOH
2102
A
HOH
2103
3
HOH
HOH
2103
A
HOH
2104
3
HOH
HOH
2104
A
HOH
2105
3
HOH
HOH
2105
A
HOH
2106
3
HOH
HOH
2106
A
HOH
2107
3
HOH
HOH
2107
A
HOH
2108
3
HOH
HOH
2108
A
HOH
2109
3
HOH
HOH
2109
A
HOH
2110
3
HOH
HOH
2110
A
HOH
2111
3
HOH
HOH
2111
A
HOH
2112
3
HOH
HOH
2112
A
HOH
2113
3
HOH
HOH
2113
A
HOH
2114
3
HOH
HOH
2114
A
HOH
2115
3
HOH
HOH
2115
A
HOH
2116
3
HOH
HOH
2116
A
HOH
2117
3
HOH
HOH
2117
A
HOH
2118
3
HOH
HOH
2118
A
HOH
2119
3
HOH
HOH
2119
A
HOH
2120
3
HOH
HOH
2120
A
HOH
2121
3
HOH
HOH
2121
A
HOH
2122
3
HOH
HOH
2122
A
HOH
2123
3
HOH
HOH
2123
A
HOH
2124
3
HOH
HOH
2124
A
HOH
2125
3
HOH
HOH
2125
A
HOH
2126
3
HOH
HOH
2126
A
HOH
2001
3
HOH
HOH
2001
C
HOH
2002
3
HOH
HOH
2002
C
HOH
2003
3
HOH
HOH
2003
C
HOH
2004
3
HOH
HOH
2004
C
HOH
2005
3
HOH
HOH
2005
C
MET
1
n
1
MET
1
A
VAL
2
n
2
VAL
2
A
ASN
3
n
3
ASN
3
A
PRO
4
n
4
PRO
4
A
THR
5
n
5
THR
5
A
VAL
6
n
6
VAL
6
A
PHE
7
n
7
PHE
7
A
PHE
8
n
8
PHE
8
A
ASP
9
n
9
ASP
9
A
ILE
10
n
10
ILE
10
A
ALA
11
n
11
ALA
11
A
VAL
12
n
12
VAL
12
A
ASP
13
n
13
ASP
13
A
GLY
14
n
14
GLY
14
A
GLU
15
n
15
GLU
15
A
PRO
16
n
16
PRO
16
A
LEU
17
n
17
LEU
17
A
GLY
18
n
18
GLY
18
A
ARG
19
n
19
ARG
19
A
VAL
20
n
20
VAL
20
A
SER
21
n
21
SER
21
A
PHE
22
n
22
PHE
22
A
GLU
23
n
23
GLU
23
A
LEU
24
n
24
LEU
24
A
PHE
25
n
25
PHE
25
A
ALA
26
n
26
ALA
26
A
ASP
27
n
27
ASP
27
A
LYS
28
n
28
LYS
28
A
VAL
29
n
29
VAL
29
A
PRO
30
n
30
PRO
30
A
LYS
31
n
31
LYS
31
A
THR
32
n
32
THR
32
A
ALA
33
n
33
ALA
33
A
GLU
34
n
34
GLU
34
A
ASN
35
n
35
ASN
35
A
PHE
36
n
36
PHE
36
A
ARG
37
n
37
ARG
37
A
ALA
38
n
38
ALA
38
A
LEU
39
n
39
LEU
39
A
SER
40
n
40
SER
40
A
THR
41
n
41
THR
41
A
GLY
42
n
42
GLY
42
A
GLU
43
n
43
GLU
43
A
LYS
44
n
44
LYS
44
A
GLY
45
n
45
GLY
45
A
PHE
46
n
46
PHE
46
A
GLY
47
n
47
GLY
47
A
TYR
48
n
48
TYR
48
A
LYS
49
n
49
LYS
49
A
GLY
50
n
50
GLY
50
A
SER
51
n
51
SER
51
A
CYS
52
n
52
CYS
52
A
PHE
53
n
53
PHE
53
A
HIS
54
n
54
HIS
54
A
ARG
55
n
55
ARG
55
A
ILE
56
n
56
ILE
56
A
ILE
57
n
57
ILE
57
A
PRO
58
n
58
PRO
58
A
GLY
59
n
59
GLY
59
A
PHE
60
n
60
PHE
60
A
MET
61
n
61
MET
61
A
CYS
62
n
62
CYS
62
A
GLN
63
n
63
GLN
63
A
GLY
64
n
64
GLY
64
A
GLY
65
n
65
GLY
65
A
ASP
66
n
66
ASP
66
A
PHE
67
n
67
PHE
67
A
THR
68
n
68
THR
68
A
ARG
69
n
69
ARG
69
A
HIS
70
n
70
HIS
70
A
ASN
71
n
71
ASN
71
A
GLY
72
n
72
GLY
72
A
THR
73
n
73
THR
73
A
GLY
74
n
74
GLY
74
A
GLY
75
n
75
GLY
75
A
LYS
76
n
76
LYS
76
A
SER
77
n
77
SER
77
A
ILE
78
n
78
ILE
78
A
TYR
79
n
79
TYR
79
A
GLY
80
n
80
GLY
80
A
GLU
81
n
81
GLU
81
A
LYS
82
n
82
LYS
82
A
PHE
83
n
83
PHE
83
A
GLU
84
n
84
GLU
84
A
ASP
85
n
85
ASP
85
A
GLU
86
n
86
GLU
86
A
ASN
87
n
87
ASN
87
A
PHE
88
n
88
PHE
88
A
ILE
89
n
89
ILE
89
A
LEU
90
n
90
LEU
90
A
LYS
91
n
91
LYS
91
A
HIS
92
n
92
HIS
92
A
THR
93
n
93
THR
93
A
GLY
94
n
94
GLY
94
A
PRO
95
n
95
PRO
95
A
GLY
96
n
96
GLY
96
A
ILE
97
n
97
ILE
97
A
LEU
98
n
98
LEU
98
A
SER
99
n
99
SER
99
A
MET
100
n
100
MET
100
A
ALA
101
n
101
ALA
101
A
ASN
102
n
102
ASN
102
A
ALA
103
n
103
ALA
103
A
GLY
104
n
104
GLY
104
A
PRO
105
n
105
PRO
105
A
ASN
106
n
106
ASN
106
A
THR
107
n
107
THR
107
A
ASN
108
n
108
ASN
108
A
GLY
109
n
109
GLY
109
A
SER
110
n
110
SER
110
A
GLN
111
n
111
GLN
111
A
PHE
112
n
112
PHE
112
A
PHE
113
n
113
PHE
113
A
ILE
114
n
114
ILE
114
A
CYS
115
n
115
CYS
115
A
THR
116
n
116
THR
116
A
ALA
117
n
117
ALA
117
A
LYS
118
n
118
LYS
118
A
THR
119
n
119
THR
119
A
GLU
120
n
120
GLU
120
A
TRP
121
n
121
TRP
121
A
LEU
122
n
122
LEU
122
A
ASP
123
n
123
ASP
123
A
GLY
124
n
124
GLY
124
A
LYS
125
n
125
LYS
125
A
HIS
126
n
126
HIS
126
A
VAL
127
n
127
VAL
127
A
VAL
128
n
128
VAL
128
A
PHE
129
n
129
PHE
129
A
GLY
130
n
130
GLY
130
A
LYS
131
n
131
LYS
131
A
VAL
132
n
132
VAL
132
A
LYS
133
n
133
LYS
133
A
GLU
134
n
134
GLU
134
A
GLY
135
n
135
GLY
135
A
MET
136
n
136
MET
136
A
ASN
137
n
137
ASN
137
A
ILE
138
n
138
ILE
138
A
VAL
139
n
139
VAL
139
A
GLU
140
n
140
GLU
140
A
ALA
141
n
141
ALA
141
A
MET
142
n
142
MET
142
A
GLU
143
n
143
GLU
143
A
ARG
144
n
144
ARG
144
A
PHE
145
n
145
PHE
145
A
GLY
146
n
146
GLY
146
A
SER
147
n
147
SER
147
A
ARG
148
n
148
ARG
148
A
ASN
149
n
149
ASN
149
A
GLY
150
n
150
GLY
150
A
LYS
151
n
151
LYS
151
A
THR
152
n
152
THR
152
A
SER
153
n
153
SER
153
A
LYS
154
n
154
LYS
154
A
LYS
155
n
155
LYS
155
A
ILE
156
n
156
ILE
156
A
THR
157
n
157
THR
157
A
ILE
158
n
158
ILE
158
A
ALA
159
n
159
ALA
159
A
ASP
160
n
160
ASP
160
A
CYS
161
n
161
CYS
161
A
GLY
162
n
162
GLY
162
A
GLN
163
n
163
GLN
163
A
LEU
164
n
164
LEU
164
A
GLU
165
n
165
GLU
165
A
DAL
1
n
1
DAL
1
C
MLE
2
n
2
MLE
2
C
MLE
3
n
3
MLE
3
C
MVA
4
n
4
MVA
4
C
DMT
5
n
5
DMT
5
C
ABA
6
n
6
ABA
6
C
SAR
7
n
7
SAR
7
C
MLE
8
n
8
MLE
8
C
VAL
9
n
9
VAL
9
C
MLE
10
n
10
MLE
10
C
ALA
11
n
11
ALA
11
C
author_and_software_defined_assembly
PISA
2
dimeric
1020
-8.0
7840
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
1_555
x,y,z
identity operation
0.0000000000
0.0000000000
0.0000000000
A
N
ILE
57
A
N
ILE
57
A
O
MET
61
A
O
MET
61
A
N
GLY
64
A
N
GLY
64
A
O
PHE
112
A
O
PHE
112
A
N
CYS
115
A
N
CYS
115
A
O
ILE
97
A
O
ILE
97
A
O
LEU
98
A
O
LEU
98
A
N
PHE
129
A
N
PHE
129
A
N
LYS
133
A
N
LYS
133
A
O
SER
21
A
O
SER
21
A
N
PHE
22
A
N
PHE
22
A
O
VAL
6
A
O
VAL
6
A
N
ALA
11
A
N
ALA
11
A
O
THR
157
A
O
THR
157
1
6.13
0.50
120.30
126.43
A
A
A
NE
CZ
NH1
ARG
ARG
ARG
19
19
19
N
1
-5.01
0.50
120.30
115.29
A
A
A
NE
CZ
NH2
ARG
ARG
ARG
19
19
19
N
1
3.07
0.50
120.30
123.37
A
A
A
NE
CZ
NH1
ARG
ARG
ARG
37
37
37
N
1
-10.50
1.60
100.20
89.70
A
A
A
CG
SD
CE
MET
MET
MET
61
61
61
N
1
12.35
1.60
100.20
112.55
A
A
A
CG
SD
CE
MET
MET
MET
100
100
100
N
1
6.71
0.80
106.30
113.01
A
A
A
CD1
CG
CD2
TRP
TRP
TRP
121
121
121
N
1
-6.20
0.80
107.30
101.10
A
A
A
CE2
CD2
CG
TRP
TRP
TRP
121
121
121
N
1
3.07
0.50
120.30
123.37
A
A
A
NE
CZ
NH1
ARG
ARG
ARG
144
144
144
N
1
-3.69
0.50
120.30
116.61
A
A
A
NE
CZ
NH2
ARG
ARG
ARG
148
148
148
N
1
A
A
NE2
CD2
HIS
HIS
54
54
-0.076
0.011
1.373
1.297
N
1
A
A
NE2
CD2
HIS
HIS
70
70
-0.068
0.011
1.373
1.305
N
1
A
A
NE2
CD2
HIS
HIS
92
92
-0.068
0.011
1.373
1.305
N
1
A
PHE
60
-120.85
-75.04
0.162
0.162
2.20
8.00
1
2.000
2.20
8.00
131
1483
0
0
1352
0.013
2.70
2.200
15.000
1CWB
7343
2.000
1
84.2
model building
X-PLOR
refinement
X-PLOR
phasing
X-PLOR
PEPTIDYL-PROLYL CIS-TRANS ISOMERASE A (E.C.5.2.1.8), CYCLOSPORIN A
THE X-RAY STRUCTURE OF (MEBM2T)1-CYCLOSPORIN COMPLEXED WITH CYCLOPHILIN A PROVIDES AN EXPLANATION FOR ITS ANOMALOUSLY HIGH IMMUNOSUPPRESSIVE ACTIVITY
1
N
N
2
N
N
3
N
N
3
N
N
A
VAL
29
A
VAL
29
HELX_P
A
GLY
42
A
GLY
42
1
1
14
A
THR
119
A
THR
119
HELX_P
A
ASP
123
A
ASP
123
5
2
5
A
GLY
135
A
GLY
135
HELX_P
A
ARG
144
A
ARG
144
1
3
10
covale
1.346
C
DAL
1
B
C
DAL
1
1_555
C
MLE
2
B
N
MLE
2
1_555
covale
1.331
C
DAL
1
B
N
DAL
1
1_555
C
ALA
11
B
C
ALA
11
1_555
covale
1.343
C
MLE
2
B
C
MLE
2
1_555
C
MLE
3
B
N
MLE
3
1_555
covale
1.346
C
MLE
3
B
C
MLE
3
1_555
C
MVA
4
B
N
MVA
4
1_555
covale
1.345
C
MVA
4
B
C
MVA
4
1_555
C
DMT
5
B
N
DMT
5
1_555
covale
1.342
C
DMT
5
B
C
DMT
5
1_555
C
ABA
6
B
N
ABA
6
1_555
covale
1.348
C
ABA
6
B
C
ABA
6
1_555
C
SAR
7
B
N
SAR
7
1_555
covale
1.349
C
SAR
7
B
C
SAR
7
1_555
C
MLE
8
B
N
MLE
8
1_555
covale
1.336
C
MLE
8
B
C
MLE
8
1_555
C
VAL
9
B
N
VAL
9
1_555
covale
1.346
C
VAL
9
B
C
VAL
9
1_555
C
MLE
10
B
N
MLE
10
1_555
covale
1.328
C
MLE
10
B
C
MLE
10
1_555
C
ALA
11
B
N
ALA
11
1_555
ISOMERASE/IMMUNOSUPPRESSANT
ISOMERASE-IMMUNOSUPPRESSANT COMPLEX, CYCLOPHILIN-CYCLOSPORIN COMPLEX, CYCLOSPORIN A, IMMUNOSUPPRESSANT, CYCLOPHILIN
CYPH_HUMAN
UNP
1
P05092
NOR00033
NOR
2
NOR00033
1
164
1CWB
2
165
P05092
A
1
2
165
1
11
1CWB
1
11
NOR00033
C
2
1
11
2
BMT
ENGINEERED MUTATION
DMT
5
1CWB
C
NOR00033
NOR
5
5
8
anti-parallel
anti-parallel
anti-parallel
anti-parallel
anti-parallel
anti-parallel
anti-parallel
A
PHE
53
A
PHE
53
A
ILE
57
A
ILE
57
A
MET
61
A
MET
61
A
GLY
64
A
GLY
64
A
PHE
112
A
PHE
112
A
CYS
115
A
CYS
115
A
ILE
97
A
ILE
97
A
MET
100
A
MET
100
A
VAL
128
A
VAL
128
A
GLU
134
A
GLU
134
A
GLU
15
A
GLU
15
A
LEU
24
A
LEU
24
A
THR
5
A
THR
5
A
VAL
12
A
VAL
12
A
ILE
156
A
ILE
156
A
GLN
163
A
GLN
163
BINDING SITE FOR CHAIN C OF CYCLOSPORIN A
Software
17
A
ARG
19
A
ARG
19
17
1_555
A
ARG
55
A
ARG
55
17
1_555
A
PHE
60
A
PHE
60
17
1_555
A
MET
61
A
MET
61
17
1_555
A
GLN
63
A
GLN
63
17
1_555
A
GLY
72
A
GLY
72
17
1_555
A
ASN
102
A
ASN
102
17
1_555
A
ALA
103
A
ALA
103
17
1_555
A
GLN
111
A
GLN
111
17
1_555
A
PHE
113
A
PHE
113
17
1_555
A
TRP
121
A
TRP
121
17
1_555
A
HIS
126
A
HIS
126
17
1_555
A
LEU
164
A
LEU
164
17
1_555
A
HOH
2098
C
HOH
17
1_555
C
HOH
2001
D
HOH
17
1_555
C
HOH
2004
D
HOH
17
1_555
C
HOH
2005
D
HOH
17
1_555
19
P 21 21 21